Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
245.00    0.00 (0.00%)
Bid:
245.00
Ask:
250.00
Spread: 5.00 (2.041%)
Market Cap: £142.92m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

Interim Management Statement

28 Nov 2014 07:00

RNS Number : 2753Y
Gleeson(M J)Group PLC
28 November 2014
 



Gleeson (MJ) Group PLC

(GLE.L)

 

Interim Management Statement

 

Gleeson (GLE.L), the urban regeneration and strategic land specialist, announces its Interim Management Statement, covering the period from 1 July 2014 to 31 October 2014.

 

Gleeson has two divisions:

 

· Gleeson Homes An urban regeneration specialist in the North of England, with a particular focus on low cost family homes

 

· Gleeson Strategic Land A strategic land promotion business, mainly in the South of England, that enhances the value of land through the planning process and sells it to developers

 

Gleeson Homes

 

The market conditions for Gleeson Homes remain healthy, with strong customer demand in all of our regions.

 

The business performed strongly during the period with 206 completions (2013: 132). The current forward order book totals 360 units (2013: 275 units). The Board expects to record an increase in completions in the year to 30 June 2015 of not less than 25% against the prior year total of 561 units.

 

The business currently has 40 active sites, compared with 33 in the corresponding period, with a further net 6 sites due to open by 30 June 2015. Gleeson Homes currently has a land pipeline of 5,116 plots, of which 3,457 are owned and 1,659 are conditionally purchased, along with a further 1,700 further plots actively being considered.

 

The Government's Help to Buy schemes remains popular, with 45% of customers taking advantage of the scheme to assist in the purchase of their home. In addition, our own bespoke purchaser assistance packages continue to be attractive.

 

Gleeson Strategic Land

 

Gleeson Strategic Land consists of 66 sites, totalling 3,913 gross acres, which have the potential to deliver approximately 21,100 units.

 

The division performed in line with expectations during the period, enhancing its portfolio, progressing sites through the planning system, and benefiting from the continuing improvement in the prices that developers are willing to pay for green field residential land in the South of England.

 

There are currently eight sites with planning permission or a resolution to grant permission. Six of these sites, which will deliver 643 plots, are being progressed for sale in the current financial year.

 

In addition, there are 13 sites where the division is currently awaiting either the determination of a planning application or the outcome of a planning appeal. It may also be possible to sell a number of these sites in the current financial year.

 

Outlook

 

The Board expects results for H1 2014 to show a strong increase over H1 2013. Based on the current level of trading in Gleeson Homes and the potential for further site sales in Gleeson Strategic Land in the second half, the Board now believes that the out-turn for the year to 30 June 2015 will exceed current expectations.

 

 

28 November 2014

Enquiries:

MJ Gleeson Group plc

Tel: +44 1252 360 300

Jolyon Harrison

Chief Executive Officer

Alan Martin

Chief Financial Officer

Instinctif

Tel: +44 20 7457 2020

Mark Garraway

Helen Tarbet

N+1 Singer

Shaun Dobson

Tel: +44 20 7496 3000

Gillian Martin

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSFMMZMVRNGDZG
Date   Source Headline
12th Feb 20254:14 pmRNSDirector/PDMR Shareholding
11th Feb 20257:00 amRNSResults for the half year ended 31 December 2024
7th Feb 202511:51 amRNSDirector/PDMR Shareholding
14th Jan 20257:00 amRNSTrading Update & Notice of Results
7th Jan 20254:28 pmRNSDirector/PDMR Shareholding
9th Dec 20244:59 pmRNSDirector/PDMR Shareholding
3rd Dec 20243:50 pmRNSDirector/PDMR Shareholding
26th Nov 20243:34 pmRNSDirector/PDMR Shareholding
15th Nov 20242:08 pmRNSResult of AGM
15th Nov 20247:00 amRNSAGM Trading Update
7th Nov 20242:44 pmRNSDirector/PDMR Shareholding
30th Oct 202410:42 amRNSDirector/PDMR Shareholding
21st Oct 20247:00 amRNSNotice of AGM
18th Oct 20244:24 pmRNSDirector/PDMR Shareholding
18th Oct 20244:19 pmRNSDirector/PDMR Shareholding
9th Oct 20244:27 pmRNSDirector/PDMR Shareholding
4th Oct 202410:18 amRNSDirector/PDMR Shareholding
30th Sep 20247:00 amRNSTotal Voting Rights
18th Sep 20247:00 amRNSAudited results for the year ended 30 June 2024
9th Sep 202410:18 amRNSDirector/PDMR Shareholding
30th Aug 20247:00 amRNSTotal Voting Rights
7th Aug 20249:41 amRNSDirector/PDMR Shareholding
31st Jul 20247:00 amRNSTotal Voting Rights
23rd Jul 20242:36 pmRNSDirector/PDMR Shareholding
23rd Jul 20241:53 pmRNSStandard form for notification of major holdings
11th Jul 20247:00 amRNSFY2024 Trading Update
8th Jul 20241:34 pmRNSDirector/PDMR Shareholding
8th Jul 20247:00 amRNSNotice of Trading Update
28th Jun 20247:00 amRNSTotal Voting Rights
6th Jun 20242:46 pmRNSDirector/PDMR Shareholding
31st May 20247:00 amRNSTotal Voting Rights
15th May 20247:00 amRNSAppointment of Joint Corporate Broker
9th May 20249:41 amRNSDirector/PDMR Shareholding
30th Apr 20247:00 amRNSTotal Voting Rights
8th Apr 20243:41 pmRNSDirector/PDMR Shareholding
3rd Apr 20244:28 pmRNSDirector/PDMR Shareholding
2nd Apr 20243:28 pmRNSDirector/PDMR Shareholding
28th Mar 20247:00 amRNSTotal Voting Rights
22nd Mar 20249:07 amRNSDirector/PDMR Shareholding
20th Mar 20241:45 pmRNSDirector/PDMR Shareholding
29th Feb 20247:00 amRNSTotal Voting Rights
26th Feb 20241:04 pmRNSDirector/PDMR Shareholding
15th Feb 20247:00 amRNSResults for the half year ended 31 December 2023
7th Feb 202411:34 amRNSDirector/PDMR Shareholding
31st Jan 20247:00 amRNSTotal Voting Rights
9th Jan 202410:50 amRNSDirector/PDMR Shareholding
9th Jan 20247:00 amRNSTrading Update & Notice of Results
29th Dec 20237:00 amRNSTotal Voting Rights
15th Dec 20232:49 pmRNSRe Directorate External Appointments
6th Dec 20234:27 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.